At A Glance:
- FDA adds Guillain-Barre Syndrome warning to Johnson and Johnson COVID vaccine.
- Guillain-Barre Syndrome is an autoimmune disease that affects the nerves.
- Various vaccines are connected to Guillain-Barre Syndrome.
The FDA has added a new warning to Janssen’s Johnson & Johnson COVID vaccine fact sheet. The warning indicates the increased risk of Guillain-Barre Syndrome; three to five times higher than expected in this population¹ with over 100 cases linked to the vaccine. Nearly all of those who developed the syndrome were hospitalized with one death reported.²
The one-dose vaccine does not use the same mRNA technology as the Pfizer and Moderna vaccines, and more closely resembles traditional vaccines used. The J&J vaccine was approved for EUA (emergency use authorization) on February 27, 2021. In April, the vaccine was halted for 10 days when it was associated with blood clots. Most of those cases were in women under the age of 50.³
What is Guillain-Barre Syndrome (GBS)?
Guillain-Barre Syndrome is a rare but serious auto-immune disorder that attacks the nerves. The severity of GBS can range from mild to severe, usually with some level of paralysis. In severe cases, the patient is unable to breathe for themselves and may result in death. Typically there is some level of weakness residual even after recovery.⁴ GBS can develop after an infection, virus, and has been associated with other vaccines in the past.
Vaccines and GBS
During the 1976 Swine Flu outbreak, GBS was noted in an increased number of people after receiving the vaccine. Since then, there have been some annual flu shots that have also been associated with an increased number of cases. In reading various case reports on the BMJ (British Medical Journal) website, there have been several cases where GBS was reported shortly after the mRNA and adenovirus (J&J and AstraZeneca) vaccines in early 2021.
In April 2021, Neurology.org noted that “(t)here is a modest risk of GBS attributed to any vaccination.”⁵
The latest information according to CDC’s VAERS website, indicates there have been over 400 cases of GBS with many also linked to the mRNA vaccines, Moderna and Pfizer.⁶
Hold the Phone — Doc’s Thoughts:
We keep hearing these vaccines are “safe and effective.” With all of the adverse events reported to the CDC’s VAERS site, I’m wondering who’s believing that anymore. Reports of blood clots, myocarditis, and now GBS come to us week after week. Suggestions not to exercise after receiving the vaccine…for HEALTHY, young athletes and servicemen.
These are the warnings we hear about. How many other adverse reactions have we not heard about? What about the 438,440 reports to the VAERS website including: 9,048 deaths; 2,486 cases of Bell’s Palsy; 3,324 heart attacks with another 2,200 myocarditis/pericarditis, 985 miscarriages, and 7,463 disabled?⁷ This is only a small part of the list! Safe and effective?
Under the EUA (emergency use authorization) it is required that the “known potential benefits outweigh the known potential risks.”⁸ We have a virus with over 99 percent survival rate. I don’t see the benefits outweighing the risks. We’ve seen reactions in young men under 30 and women under 50. These are generally healthier populations that would recover from the virus itself. We don’t even know what the long-term risks are yet. The studies haven’t been completed!
The FDA is hearing they need to fully approve these vaccines to overcome vaccine hesitancy. Twenty-seven concerned experts put their names on the line when they filed a citizen’s petition for the FDA to “slow down and get the science right.”
Even experts who have worked on these vaccines, and have been vaccinated themselves are raising concerns. At The Wellness Way, we will always advocate for medical freedoms and informed consent. With so little of the adverse events on warning labels or available for consumers to read, how will they be able to make an educated, informed decision to consent to the vaccines?
³https://www.goodrx.com/covid-19/johnson-and-johnson
⁵https://n.neurology.org/content/96/22/1052
⁷https://www.openvaers.com/covid-data
⁸https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained
